Prof. Jiang Zhihong’s team under the State Key Laboratory of Quality Research in Chinese Medicine of Macau University of Science and Technology, with the support of the Science and Technology Development Fund (FDCT), has collaborated with the team of Academician Zhong Nanshan at the Guangzhou Medical University and the Guangzhou Pharmaceutical Holdings Limited to enhance the antiviral effectiveness of the compound Banlangen. They have jointly conducted a breakthrough scientific research on the antiviral properties of Banlangen.
 
    Taking the geographical advantage of the Hengqin Branch of the Key Laboratory, the team has carried out relevant research work and conducted a thorough analysis of the chemical components of Baphicacanthus Root (Nanbanlangen) using ultra-high-performance liquid chromatography (UHPLC) combined with quadrupole time-of-flight mass spectrometer (QTOF-MS). The team has published over 20 scientific research papers related to Banlangen and obtained 15 authorized patents. They have also obtained in Macao the medical registration approval “Compound Banlangen Granules (Low Sugar)” adopting the same name and formulation, which has been the first approved innovative oral traditional Chinese medicine (TCM) following the same name and formulation, since the implementation of the Law on the Pharmaceutical Activity in the Field of Traditional Chinese Medicines and the Registration of Proprietary Chinese Medicines in Macao. This achievement sets a precedent for mainland China to achieve market approval for innovative registered proprietary Chinese medicines in Macao and promotes the TCM’s international development. It also serves as a brilliant practice for the collaboration between Guangdong and Macao, as well as the coordinated development of the Guangdong-Hong Kong-Macao Greater Bay Area in building a highland for the TCM industry.